t had been predicted in the fi rst paper ever published concerning the physiological eff ects of weightlessness in 1948 that there is a signifi cant alteration of cardiovascular function due to the loss of baroreceptor tonus (similar to bed rest patients). 18 However, only minor changes in cardiovascular parameters were observed in monkeys on suborbital fl ights experiencing 2 min of weightlessness in 1952. 33 On the 1959 suborbital primate fl ight of Able and Baker, there were no cardiovascular abnormalities observed by telemetry during the 8.3 min of weightlessness. Only tachycardia and bradycardia were observed as expected during the acceleration and deceleration portions of the fl ight. 29 In 1961 it was demonstrated that water immersion was analogous to weightlessness because the hydrostatic pressure eff ects of body fl uids due to gravity were minimalized. 26 , 27 It was found with prolonged (1 wk) water immersion that 11% of blood volume (600 cc) was shift ed from the lower extremities and redistributed to the thorax, where atrial cardiac volume receptors were activated by the recently discovered Henry-Gauer refl ex.
R E V I E W A R T I C L E
I t had been predicted in the fi rst paper ever published concerning the physiological eff ects of weightlessness in 1948 that there is a signifi cant alteration of cardiovascular function due to the loss of baroreceptor tonus (similar to bed rest patients). 18 However, only minor changes in cardiovascular parameters were observed in monkeys on suborbital fl ights experiencing 2 min of weightlessness in 1952. 33 On the 1959 suborbital primate fl ight of Able and Baker, there were no cardiovascular abnormalities observed by telemetry during the 8.3 min of weightlessness. Only tachycardia and bradycardia were observed as expected during the acceleration and deceleration portions of the fl ight. 29 In 1961 it was demonstrated that water immersion was analogous to weightlessness because the hydrostatic pressure eff ects of body fl uids due to gravity were minimalized. 26 , 27 It was found with prolonged (1 wk) water immersion that 11% of blood volume (600 cc) was shift ed from the lower extremities and redistributed to the thorax, where atrial cardiac volume receptors were activated by the recently discovered Henry-Gauer refl ex. 19 Th is refl ex produced a pronounced compensatory diuresis over 3 d, which resulted in a loss of plasma volume, 47 followed by orthostatic intolerance on return to the normal nonimmersion environment. 28 It was predicted that the same eff ect would occur in weightlessness during spacefl ight. Data from the Mercury fl ights of Schirra (MA-8) in 1962 and Cooper (MA-9) in 1963 both showed a signifi cant decrease in body weight, fl uid output exceeding intake, and the excretion of a large amount of very dilute urine (2360 cc, specifi c gravity of 1.003 on MA-9). Moderate reductions in orthostatic tolerance were noted by tilt testing postfl ight on Cooper, but were not operationally signifi cant. Th ese fi ndings were more pronounced with the 22 orbit fl ight of MA-9 than with the 6 orbit fl ight of MA-8. 28 , 44 Cooper (MA-9) developed presyncope symptoms and had a heart rate of 188 on standing aft er recovery. Tilt testing at 1, 3, and 6.5 h aft er landing showed an average heart rate increase of 48% (compared to 29% prefl ight). Although future U.S. spacefl ights universally found a loss of plasma volume postfl ight, brisk diuresis in the early in-fl ight period was rarely observed, probably secondary to fl uid restriction in the immediate prefl ight period by the astronauts to avoid urination during the launch phase.
In 1964, it was demonstrated that following 4 wk of bed rest, the same duration as the planned USAF Manned Orbiting Laboratory (MOL) missions, orthostatic intolerance was present that was less intense and more variable than water immersion. 50 During the Gemini Program (1965) (1966) , pre-and postfl ight 70° tilt table tests for orthostatic tolerance became a standard protocol and showed consistently elevated heart rates (increased by 17 -105%), reduced pulse pressure, and increased pooling of fl uids in the lower extremities in the early postfl ight period which returned to normal aft er 50 h. Th ere was one case of tilt test syncope out of 16 subjects. 35 , 56 Given that headward fl uid shift s are associated with the development of orthostatic intolerance, it follows that prevention or reversal of headward fl uid shift s might reduce or eliminate orthostatic intolerance. Intermittent venous occlusion with extremity tourniquets simulating hydrostatic pressure eff ects was eff ective in maintaining cardiovascular adaptability during water immersion 25 and bed rest subjects as well.
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Early Development of Lower Body Negative Pressure
Lower body negative pressure (LBNP) is the application of subatmospheric pressure to the lower portion of the body to pool blood in the lower extremities. Th e level of negative pressures covers a wide range, from 5 mmHg to 100 mmHg and the duration of negative pressure can be from minutes to hours. Essentially there is a shift of fl uid volume from the upper body to the lower body. Th e fl uid defi cit is detected by the upper body vascular pressure and stretch receptors, and triggers an integrated systemic-wide response and is a test for orthostatic intolerance. LBNP hardware provides only a small pressure change to the lower body (50 mmHg is about 1 psi). Interestingly, this pressure over the cross-sectional area of the body at the level of the waist seal of the LBNP device approximates the weight of the body in a 1-G environment. 8 Th e origins of the design and development of the fi rst LBNP device are obscure. Dr. Duane Graveline was an Air Force fl ight surgeon with the USAF School of Aerospace Medicine (SAM). He was involved in researching the cardiovascular eff ects of prolonged water immersion and found that it accurately predicted the eff ects of spacefl ight with the development of diuresis and orthostatic intolerance. During his research on water immersion as a spacefl ight analogue, he served as a test subject and spent 7 d continuously immersed underwater from his neck down. He was one of six scientists to be selected into the 1965 astronaut group, but unfortunately left the program before having fl own in space. Dr. Graveline claims that he built the fi rst prototype LBNP device at Brooks AFB in 1962 -1963. Th is project was possibly initiated aft er conversations that Dr. Graveline had with Dr. Earl Wood of the Mayo Clinic and Dr. Oleg Gazenko from the Institute of Biomedical Problems (IBMP) of the Soviet Academy of Sciences. Although we have found no independent documentation of this, Dr. Graveline was doing the right research (water immersion to study cardiovascular changes as an analogue to spacefl ight) in the right place (SAM) at the right time (1960 -1963 ) and Graveline ' s claim of developing the fi rst LBNP is credible.
Following is a discussion by Dr. Graveline on his development of the fi rst LBNP device:
" My extremity tourniquet countermeasures for fl uid redistribution during water immersion weightlessness were an adaptation from Dietrick, Whedon and Schor's oscillating bed. Th e LBNP device that I developed at SAM was just an adaptation of my extremity tourniquet concept. When I developed the original LBNP prototype, I had the shop people build me " half a casket " with a rubber waist seal at one end connected to a simple vacuum pump. Th e shop foreman would not get inside it so I got into it myself. I determined that the waist seal was sufficiently tight, put a blood pressure cuff on my arm, and started applying vacuum at 5 mmHg pressure while recording serial blood pressure and heart rate. Th at seemed safe enough so I increased the vacuum to 10 mmHg and could feel a physiologically signifi cant response with an increased diastolic pressure and slight drop in the systolic pressure. Aft er a good deal of experimentation, I fi nally settled on 30 mmHg negative pressure as the setting that best mimicked standing erect in a one-G fi eld, with values roughly the same as my normal baseline tilt test. I believed that it had the potential to prevent the loss of orthostatic responsiveness by incorporating it into a sleep chamber during spacefl ight, but I never had a chance to work on this. Th e fi rst paper describing the cardiovascular eff ects of LBNP was published in 1965 by Stevens and Lamb at the SAM, who apparently received Graveline's prototype and further developed it. 58 Th ey showed that LBNP was an excellent test for orthostatic intolerance and had advantages over tilt testing in that it was more controlled and did not directly aff ect cerebral blood fl ow. Data obtained using a LBNP device (studying the eff ects of sudden volume overload with the termination of LBNP) had been presented earlier at the American Physiological Association meeting in August of 1963 by Greenfi eld et al. 30 and later published. 6 , 7 , 31 Th eir original LBNP device was similar to the later Soviet LBNP devices in that there was no saddle support. Gilbert and Stevens showed that 60 mmHg LBNP was very similar in cardiac response to 90° tilt-table testing and so was an equivalent method of testing for orthostatic intolerance. One important diff erence was that tilt testing decreased cerebral blood pressure, which increased the baroreceptor response and increased venous tone as compared to LBNP. 22 Th ey also showed that LBNP was a potent stimulus to water and sodium retention in supine patients and so potentially could be used as a future countermeasure to orthostatic intolerance. 23 Water immersion and 500 cc venesection was found to give similar LBNP responses and was an indication of similar orthostatic intolerance. 53 Musgrave et al. showed that the lower extremity volumetric changes that occurred with the use of 40 mmHg LBNP was equivalent to the upright posture. However, higher levels of LBNP were necessary to obtain the same level of heart rate response as upright tilt testing due to the nonstimulation of the carotid baroreceptors with LBNP. 54 Although some researchers found individual variances with LBNP testing, 69 it 55 Further research demonstrated that LBNP (30 mmHg for 8-10 h/d) maintained plasma volume and prevented orthostatic intolerance in bed rest (duration of 1 to 4 wk) subjects. 48 , 59 Th is was true even if only used during the last 2 d of prolonged bed rest. 45 , 60 It was found that even brief LBNP exposure increased the levels of renin, angiotensin I, ADH, and catecholamines. 24 
Apollo Program
LBNP testing with a fi nal pressure of 50 mmHg in a ramped up protocol over 15 min was used routinely pre-and postfl ight during the Apollo Program (on Apollo 7, 8, 9, 15, 16, and 17) as it was felt to be easier to standardize than tilt testing and could be applied incrementally ( Fig. 1 ) . Th ere was also a desire to generate data to compare to the upcoming Skylab Program. Th e Apollo crewmembers all showed decreased body weight (average of 5%), decreased plasma volume, decreased leg volume, and increased but variable orthostatic intolerance by LBNP and tilt testing. Average heart rate response to 50 mmHg LBNP was 109 bpm postfl ight as compared to 70 bpm prefl ight. 4 Interestingly, cardiothoracic ratio postfl ight was decreased except for in the crewmembers that had performed lunar extravehicular activities (EVA), indicating that the brief exposure to lunar gravity was protective of cardiac deconditioning.
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Skylab Program
Th ere were tentative plans to deploy an in-fl ight LBNP device on the MOL missions, so a prototype was developed at Brooks AFB in 1966. However, the MOL program was canceled in 1969. Th e Skylab Program (1973-74) made use of prefl ight, infl ight, and postfl ight LBNP using the same 50 mmHg ramped up protocol over 15 min as in the Apollo Program. In-fl ight LBNP was performed on each crewmember every 3-4 d ( Fig. 2 ) .
Skylab also measured body mass for the fi rst time in fl ight using a spring-mass oscillator. 62 Th e 28-d Skylab 2 mission (the fi rst manned mission) found that a large volume of fl uid was shift ed out of the legs (decreased leg circumference) and body mass decreased early in the fl ight. Orthostatic intolerance was refl ected by early termination of LBNP (for termination parameters see Fig. 3 ), which was present on some of the LBNP trials during the fi rst week. In-fl ight heart rate increases plateaued at 5-10 d. Calf volume increases were induced by LBNP and were greater than prefl ight and postfl ight LBNP. 40 Although the postfl ight LBNP responses were not more severe than the Apollo data, the time to return to normal in the postfl ight period was slower. In-fl ight LBNP appeared to predict the degree of postfl ight orthostatic intolerance. 39 , 40 Th e 59-d Skylab 3 mission found that in-fl ight orthostatic intolerance paralleled the fi ndings on Skylab 2, but stabilized at 6-8 wk and that postfl ight orthostatic intolerance recovery was actually shorter than on Skylab 2. In-fl ight orthostatic intolerance for each individual accurately predicted their postfl ight response. 40 , 41 Systolic time interval abnormalities measured postfl ight during LBNP indicated that there was a small decrease in cardiac contractility. Body mass decreased by 2.5 kg (3.8%) and leg volume decreased by 12.5%. 61 However, the magnitude of the decrease in leg volume measurements was the same as in Skylab 3.
40 Th e fi rst 2 mo of in-fl ight LBNP data from Skylab 3 and 4 indicate that the astronauts became adapted aft er 4 wk to the orthostatic stress provided by LBNP ( Fig. 4 ) .
Soviet Experience
Early Soviet spacefl ight missions also showed evidence of fl uid shift s in fl ight, which is critical to understanding the results of LBNP studies. Th e Soviets found a decrease in body mass postfl ight (average loss of 2.5 kg) and signifi cant postfl ight orthostatic intolerance. Th e last three Vostok cosmonauts had elevated heart rates on tilt testing postfl ight. Two of the three Voskhod cosmonauts showed decrease stroke volume and cardiac output (26 -47% reduction) during postfl ight tilt testing. Out of 13 short duration Soyuz cosmonauts, 9 had elevated heart rates on postfl ight tilt testing. On the 18-d Soyuz-9 mission (1970), orthostatic intolerance was unexpectedly severe. 20 , 43 Both cosmonauts had presyncopal symptoms and standing heart rates were increased by 63% and 65%. Pulse pressure was reduced by 71%. Th ese exaggerated responses resolved aft er several days. Th e Soviet Salyut space station missions showed decreased body mass early in fl ight using an in-fl ight springmass oscillator. Ultrasound examination during Salyut-7 showed that jugular vein diameter was considerably increased in fl ight.
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In-fl ight LBNP was fi rst performed with the Veter LBNP device on Salyut-1 in 1971 ( Fig. 5 ) . Th e Soviets, therefore, were the fi rst to use LBNP during spacefl ight, fully 2 yr before the fi rst manned Skylab mission. Th e Chibis LBNP suit was then developed (as was Veter) at IBMP by Oleg Gazenko and used on four Salyut fl ights, the Mir space station, and the Russian segment of the International Space Station (ISS). A newer version, Chibis-M, was developed in 2012 for use on the ISS. Chibis did not have a saddle to support the body (possibly designed for ambulation during LBNP) so that during decompression the feet pressed against the bottom of the collapsible corrugated chamber, which shortened and applied force against the feet proportional to the decompression level. Th is activation of the skeletal musculature of the legs counteracted the lower extremity venous pooling and acted as an additional countermeasure. 12 Loading the lower extremities during LBNP increases muscle tone and decreases venous capacitance and so provides a protective eff ect to the fl uid shift s that are induced by LBNP. In the American LBNP confi guration, used aboard Skylab and the Space Shuttle, a saddle supports the astronaut so that the feet do not contact the bottom of the chamber, and vascular engorgement is not countered by muscular contraction. Th is minimizes skeletal muscle involvement and allows measurements of changes in leg volume and muscle sympathetic nerve activity for research purposes. Comparing data between the two LBNP devices shows that heart rate increases are less with the Chibis suit due to this lower extremity muscle activity. 20 Th e IBMP protocol was 2 min at 25 mmHg and then 3 min at 35 mmHg. Unaccountably, fi rst reports were that heart rate and mean arterial blood pressure response to infl ight LBNP during the fi rst 2 wk was not found to be significantly diff erent than prefl ight responses. 20 However, on the 30-d and 63-d Salyut-4 (1975) missions, in-fl ight LBNP was performed weekly and consistently found elevated heart rates. Salyut-6 (1977 Salyut-6 ( -1981 and Salyut-7 (1982 Salyut-7 ( -1986 ) hosted 11 long duration missions (over 65 d). In-fl ight LBNP showed increased heart rate, increased total peripheral resistance, and increased left ventricular ejection time as compared to prefl ight values. However, there were no decrements noted with increasing fl ight duration and postfl ight orthostatic intolerance was not increased with longer duration fl ights as compared to short duration fl ights. 20 In-fl ight individual response was predictive of postfl ight orthostatic intolerance. Reportedly, several individual crewmembers did not show an exaggerated response to in-fl ight LBNP and had no postfl ight orthostatic intolerance.
Th e Soviets used in-fl ight LBNP to evaluate other countermeasures for postfl ight orthostatic intolerance. Th e usual exaggerated heart rate response was not found with the last LBNP that was performed on the 1975 Soyuz-18/Salyut-4 fl ight (63 d) with the ingestion of 4 g NaCl and 1000 cc water as an additional countermeasure prior to landing day ( Fig. 6 ) . Beginning with Salyut-6, countermeasures were standardized to prevent orthostatic intolerance which included regular exercise, LBNP during the last 2-5 d before landing, and ingestion of salt water (6-9 g NaCl in 900-1200 cc water). At least subjectively, the Soviets were convinced that these countermeasures were benefi cial and eff ective. 11 -13 , 71 In-fl ight rheography demonstrated that spacefl ight causes a decrease in the total peripheral resistance that has regional variation. 20 , 63 Th e use of in-fl ight LBNP appears to cause an increase in total peripheral resistance by rheography.
21 Th e use of thigh level occlusion devices ( " Bracelet " ) by the Russians causes lower extremity fl uid sequestration and exerts commensurate measurable eff ects on cardiac performance in microgravity, 32 and prevents the subjective discomfort of initial fl uid redistribution during spacefl ight, but does not change the response to in-fl ight LBNP or post-landing orthostatic intolerance. 15 Th e new Russian " Chibis-M " suit (also called " PVK-2 " ) was developed to encompass a broader range of crewmember anthropometric parameters. It also has more reliable depressurization and contains a computer controller with preloaded programs. Like the original Chibis ( " PVK-1 " ), the Chibis-M suit is designed with corrugated pants which enable the axial compression of the shell. Th e Russians continue to use a version of the LBNP protocol with the Chibis-M suit at the end of mission time frame onboard the ISS as a countermeasure for postlanding orthostatic intolerance.
LBNP Bed Rest Studies
In 1976, Soviet bed rest studies showed that 2 12° (as compared to 2 4° and 2 8°) head down tilt for 5 d exactly replicated the subjective symptoms and tilt test response of spacefl ight. 42 In the United States in 1979, 2 5° head-down tilt for 24 h closely matched spacefl ight data with regard to decrease in blood volume, leg volume, weight loss, and response to LBNP. 5 U.S. ground studies revealed that LBNP resulted in decreased end diastolic volume and therefore decreased stroke volume, but did not infl uence cardiac contractility. 1 Women were found to be less tolerant of LBNP at 60 mmHg than men. 51 LBNP was found to be more reliable as an indicator of orthostatic intolerance as compared to 70° tilt or a stand test. 36 In 1977, 4 h of LBNP at 30 mmHg and saline loading at the end of 1 wk of bed rest was found to restore the plasma volume defi cit and to be completely protective of orthostatic intolerance. 37 Prolonged bed rest (2 -4 wk) and spacefl ight (11 -84 d) were found on analysis in 1979 to both result in decreased blood volume and plasma volume and show very similar post-study LBNP responses. 38 One diff erence was that blood volume defi cits occurred in spacefl ight within several days, whereas bed rest defi cits occurred gradually over a longer period of time. Again, 4 h of LBNP at 30 mmHg and saline loading at the end of the bed rest study was found to restore the volume defi cits, to be protective of orthostatic intolerance, and was proposed as a future countermeasure. It was noted in this study that although the plasma volume defi cit post-spacefl ight was restored within 18 h, orthostatic intolerance lasted several days, indicating that there were other factors involved besides volume defi cit. It is now known that at least some of these factors include a decrease in the total peripheral resistance post-landing due to a blunting of the cardiac baroreceptor refl ex and a lack of responsiveness to catecholamines.
In 1999, Watenpaugh 64 developed an LBNP prototype that self-generated the decreased pressure in a collapsible chamber during " leg-press " type exercise that prevented lower extremity venous pooling by leg muscle activity similar to the Chibis device. Th is simplifi ed the LBNP device and again was oriented as an orthostatic countermeasure device and not as a research tool. Th is concept is now being fl own on the Chinese space station. 70 Exercise during LBNP in bed rest studies has been shown to reduce orthostatic intolerance and maintain exercise capacity. 65 , 66 Th ere is some evidence in bed rest studies that exercise with LBNP prevents the vascular deconditioning (decreased total vascular resistance) that was found on later Shuttle fl ights. 
Shuttle Program
Th e development of the Shuttle Program raised new concerns about postfl ight orthostatic intolerance as Shuttle landing exposed the pilot to as much as 2.0 g in the G z (head to foot) axis. All previous spacefl ights required minimal pilot function and forces that were in the easily tolerated G x (chest to back) axis. On the fi rst four short duration Shuttle fl ights, two astronauts (the crew of STS-4) out of eight crewmembers ingested 1 L of isotonic saline and showed a marked diff erence in postfl ight orthostatic intolerance with less heart rate increase on stand testing. 10 Out of 26 astronauts, 17 performed saline loading just prior to re-entry on the fi rst 8 Shuttle fl ights and had a decrease in presyncope and a decreased heart rate response to stand testing by 29%. 9 Th ereaft er, saline loading was adopted as standard protocol on all subsequent Shuttle fl ights. Detailed leg volume studies in fl ight showed that up to 2 L of fl uid was lost from the lower extremities within 10 h of fl ight. Th is volume was replaced within 1.5 h of landing, although some volume loss was present 1 wk post-landing. 52 , 61 Th ere was found to be a rapid loss of plasma volume during the fi rst day of spacefl ight (17%), which caused an increase in the hematocrit, but did not cause an immediate diuresis. Th ere was some adaptation that occurred which adjusted this to a 10% reduction at 12 d. 14 , 46 LBNP was used during the Shuttle Program during the Extended Duration Orbiter Project (1989-1995) both to investigate in-fl ight cardiovascular responses and as a countermeasure to postfl ight orthostatic intolerance. Th e hardware developed was a fabric cylinder with collapsible internal bracing that required minimal stowage volume. A ramp protocol was used that gave stepwise decompression in 10 mmHg increments until 50 mmHg was reached, with a total LBNP time of 40 min. A soak protocol was tested as a potential countermeasure for application on the day before landing which used 30 mmHg for 4 h. Th e soak was fi rst used in fl ight with concurrent saline ingestion and had a benefi cial eff ect which was manifested by a diminished heart rate response to the LBNP ramp protocol the next day. However, this benefi t was lost by 2 d aft er the soak treatment. Th e soak treatment concurrent with saline ingestion was then demonstrated as a countermeasure the day before landing and LBNP treated astronauts showed less heart rate increase and less decrease in systolic blood pressure as compared to the non-LBNP astronauts during stand testing. Although the LBNP soak treatment has a protective eff ect on post-landing orthostatic intolerance, the 5 h required to treat each individual makes it impractical to use.
Tolerance to ground-based LBNP was found to not be related to leg volume changes alone. 57 It was found that the loss of plasma volume was not the sole cause of orthostatic intolerance post-spacefl ight. In a study of Shuttle astronauts, 9 out of 14 (64%) developed presyncope aft er a 10 min stand test postlanding. Comparison of orthostatic tolerant and intolerant astronauts showed no diff erences in heart rate increases, cardiac output, or decreases in stroke volume. However, the tolerant astronauts had a more profound increase in total peripheral resistance with standing. 8 Further biomedical research on the Shuttle discovered that short-term spacefl ight resulted in blunting of the carotid baroreceptor-cardiac refl ex, which did not return to normal until several days post-landing and that this contributed to orthostatic intolerance. 16 Shuttle astronauts were found to have a lack of responsiveness to catecholamines postlanding. Although increased levels of norepinephrine were present with post-landing stand testing, total peripheral resistance was not increased as expected. 68 It was also found that a hypoadrenergic response with decreased plasma norepinephrine and decreased peripheral vascular resistance occurred with orthostatic stress following spacefl ight in a group of astronauts who were relatively more susceptible to presyncope post-landing. 17 Women are more susceptible than men in that they have lower total peripheral resistance and a less pronounced adrenergic response to orthostasis. 67 
Future Research
Th e intense research interest in Visual Impairment and Intracranial Pressure (VIIP) syndrome recently discovered during long duration ISS missions has created a new role for in-fl ight LBNP research to study physiological fl uid shift s in weightlessness. A thorough investigation will be undertaken jointly by American and Russian investigators on ISS beginning in 2015, specifi cally to test the hypothesis that an acute reversal of the head-ward fl uid redistribution using LBNP may prevent increases in intracranial pressure and visual impairment. 72 
